BC Extra | Dec 18, 2019
Financial News

With new name, Epirium snags $85M series A to develop hormonal therapy for muscular dystrophies

Ten-year-old Cardero Therapeutics Inc. relaunched Wednesday as Epirium Bio with a tranched $85 million series A led by Longitude Capital and Arch Venture Partners, IP around a new hormonal pathway as well as human proof-of-concept...
Items per page:
1 - 1 of 1
BC Extra | Dec 18, 2019
Financial News

With new name, Epirium snags $85M series A to develop hormonal therapy for muscular dystrophies

Ten-year-old Cardero Therapeutics Inc. relaunched Wednesday as Epirium Bio with a tranched $85 million series A led by Longitude Capital and Arch Venture Partners, IP around a new hormonal pathway as well as human proof-of-concept...
Items per page:
1 - 1 of 1